Racial/Ethnic Disparities in Ophthalmology Clinical Trials Resulting in US Food and Drug Administration Drug Approvals From 2000 to 2020

Authors:

Abstract
Epidemiological studies have demonstrated myriad racial/ethnic and sex variations in the prevalence and disease course of common ocular diseases, including open-angle glaucoma (OAG), age-related macular degeneration (AMD), and diabetic retinopathy (DR). For example, there have been significant racial/ethnic differences in the rates of OAG, AMD, and DR among minority groups in landmark studies, including the Baltimore Eye Survey,1,2 the Barbados Eye Study,3-5 the Salisbury Eye Evaluation Project,6-8 the Proyecto Ver Study,9-11 the Los Angeles Latino Eye Study (LALES),12-14 the Multi-Ethnic Study of Atherosclerosis15,16 as well as studies using data from the National Health and Nutrition Examination Survey.17-19 These population-based epidemiological studies established critical racial and demographic differences, but historically they have not been sufficiently nuanced to be representative of the entire US population.20